Susanne Jung, Christopher Hackenbruch, Jens Bauer, Jonas S. Heitmann, Yacine Maringer, Melek Tutku Oezbek, Annika Nelde, Monika Denk, Lisa Zieschang, Christine Kammer, Pavlos Missios, Irina Bonzheim, Martin Ebinger, Helmut R. Salih, Michael Bitzer, Juliane S. Walz. "FusionVAC22_02, a phase I clinical trial in progress: Adjuvant
                    <i>DNAJB1-PRKACA</i>
                    fusion transcript–based peptide T-cell activator for fibrolamellar hepatocellular carcinoma (FLC) and other tumor entities carrying the oncogenic driver fusion.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps4270